Literature DB >> 8382754

In situ numeric analysis of centromeric regions of chromosomes 1, 12, and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma in situ of human testis.

L H Looijenga1, A J Gillis, W L Van Putten, J W Oosterhuis.   

Abstract

BACKGROUND: No detailed data are available concerning the possible chromosomal heterogeneity within testicular germ cell tumors (TGCT) of adults. In addition, little is known about the chromosomal constitution of carcinoma in situ (CIS) of the human testis, the precursor of TGCTs, and the possible relation with the different histological tumor types (seminomas (SE), nonseminomatous (TGCTs (NS). EXPERIMENTAL
DESIGN: Interphase cytogenetics in combination with immunohistochemistry was performed on tissue sections of SE, NS, and their adjacent CIS to study the numerical distributions of centromeric regions of chromosomes 1, 12, and 15.
RESULTS: No differences in chromosomal constitution were found between CIS adjacent to SE and the invasive tumor itself. NS showed a significant lower number of copies of chromosome 15 than SE, which was also found for the adjacent CIS. In addition a significantly higher number of copies of chromosome 12 was found in CIS adjacent to SE compared with CIS adjacent to NS. Invasive NS showed a significantly higher chromosome 1 and 12 copy number compared with its adjacent CIS.
CONCLUSIONS: Net loss of chromosomes during tumor evolution can explain the differences between SE and NS and also between their adjacent CIS. Based on these results, we hypothesize that CIS-S may progress not only into SE but also into CIS-NS. It is conceivable, therefore, that NS may evolve from SE or from CIS-NS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382754

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

1.  X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

Authors:  L H Looijenga; A J Gillis; R J van Gurp; A J Verkerk; J W Oosterhuis
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

3.  Confirmation of the copy number of chromosome 1 in interphase nuclei from paraffin sections of breast tumours by fluorescence in situ hybridization.

Authors:  M L Loupart; R Walker; W Brammar; J Varley
Journal:  Chromosome Res       Date:  1995-11       Impact factor: 5.239

4.  Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance.

Authors:  E Rajpert-De Meyts; M Kvist; N E Skakkebaek
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

5.  Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.

Authors:  B Summersgill; H Goker; S Weber-Hall; R Huddart; A Horwich; J Shipley
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

6.  Glycolipids of human primary testicular germ cell tumours.

Authors:  R A Olie; B Fenderson; K Daley; J W Oosterhuis; J Murphy; L H Looijenga
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

7.  Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model.

Authors:  S W Faulkner; D A Leigh; J W Oosterhuis; H Roelofs; L H Looijenga; M L Friedlander
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

8.  Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults.

Authors:  B Summersgill; P Osin; Y J Lu; R Huddart; J Shipley
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

9.  Risk factors for testicular germ cell tumours by histological tumour type. United Kingdom Testicular Cancer Study Group.

Authors:  C A Coupland; C E Chilvers; G Davey; M C Pike; R T Oliver; D Forman
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.